AdaptHealth reports Q4 EPS 34c, consensus 28c

Reports Q4 revenue $856.65M, consensus $829.19M. Reports adjusted EBITDA was $200.6M compared to $204.6 M , a decrease of 2.0%.Cash flow from operations was $150.4M , a decrease from $155.3M , and free cash flow was $73.1M , an increase from $66.6M. “Over the course of the second half of 2024, we continued to make progress on our five areas of focus, which include our One Adapt initiative, accelerating the application of AI and automation, increasing our clinical relevance, delivering organic growth, and strengthening our balance sheet,” said Suzanne Foster, Chief Executive Officer of AdaptHealth (AHCO). “The progress we have made helped drive our solid fourth quarter results and, more importantly, is strengthening our foundation for long-term success and growth.”